Board of Directors
In September 2011 Jaymin was appointed to the Board of Directors of ProfactorPharma as a non-executive director. And in August 2016 Jaymin was named, and is currently serving as the Chief Executive Officer.
CFO, Founder and Board Member
He was the company’s first CEO completing the first seed round with Kelvin Capital in 2013 and now serves as Chief Financial Officer.
Dr. David Brown
David joined the Board in 2013 as part of the Kelvin Capital orchestrated investment.
Dr. V Paul Gerskowitch
Dr. Ian Fotheringham
Ian Fotheringham received a Ph.D. in Molecular Biology with Professor David Sherratt at the University of Glasgow in 1986. Joining the NutraSweet division of Monsanto Corporation in Chicago IL, he then spent 6 years developing microbial strains for the manufacture of L-phenylalanine and the peptide sweetener Aspartame. From 1992, with NSC Technologies, Great Lakes Fine Chemicals, Richmond Chemical Corp and Ingenza, he has continued to develop large-scale industrial bioprocesses to produce chiral compounds, including non-proteinogenic amino acids and carbohydrates. He has published 30 papers and holds 7 current patents.
Professor John H McVey PhD, FRCPath
Founder & Chief Scientist
Director of Regulatory Affairs and QA, Founder